← Back to headlines
Analyst Reinstates Merck with 'Neutral' Rating and $125 Price Target
An analyst has reinstated coverage of Merck (MRK) with a 'Neutral' rating and set a price target of $125.
12 May, 19:01 — 12 May, 19:01
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
23m ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
11h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
14h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
22h ago